Behavioral Pharma

Executive Summary

Behavioral Pharma is a private biotechnology company headquartered in San Diego, California, focused on developing integrated solutions for behavioral and mental health disorders. Founded in 2017, the company combines digital therapeutics with pharmacological treatments to create more effective, accessible, and personalized interventions for patients. By leveraging digital platforms to enhance drug efficacy and patient adherence, Behavioral Pharma aims to address significant unmet needs in the mental health space, which includes depression, anxiety, and other behavioral disorders. The company's approach seeks to bridge the gap between traditional pharmaceuticals and digital health, potentially improving outcomes and reducing the overall burden on healthcare systems. Despite being in a relatively early stage with limited public information, Behavioral Pharma's focus on the rapidly growing digital health and mental health markets positions it for potential growth, pending successful development and validation of its integrated platform.

Upcoming Catalysts (preview)

• Q3 2026Topline results from Phase 2 clinical trial of lead compound for major depressive disorder40% success
• Q2 2027Regulatory submission for digital therapeutic component as a companion to pharmacological treatment50% success
• Q4 2026Announcement of strategic partnership or licensing agreement with a larger pharmaceutical or digital health company60% success